foto

Dr. T.S. Boender BSc MSc PhD

Position
Postdoc
Main activities
Research
Specialisation
Infectious disease epidemiology & public health
Focus of research

 

I am an enthusiastic postdoctoral researcher in the field of HIV, specialised in the epidemiological analysis of large observational cohorts studies. I am involved in several multi-country HIV cohort studies and collaborations, in both resource-rich and resource-limited settings.

 

My research addresses clinical, public health and policy-related questions. Key themes are: the response to antiretroviral therapy of HIV, treatment monitoring and switch strategies, drug resistance, viral hepatitis, and quality of care.

My colleagues and I at Stichting HIV Monitoring are responsible for the national surveillance and monitoring of HIV in the Netherlands.

 

Key publications
  • Boender S. Long-term effects of HIV treatment in sub-Saharan Africa: from access to quality. S.l.: s.n.; 2016. 265p. ISBN 978-94-6169-841-4 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Rinke de Wit TF, Boele van Hensbroek M; copromotor(s): Sigaloff KCE, Calis JCJ)
  • Boender TS, Hoenderboom BM, Sigaloff KCE, Hamers RL, Wellington M, Shamu T, Siwale M, Labib Maksimos EEF, Nankya I, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Ondoa P, Rinke de Wit TF, Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. CLIN INFECT DIS 2015;61 (11):1749-1758 [PubMed]
  • Boender TS, Sigaloff KCE, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, Ford N, Rinke de Wit TF, Bertagnolio S, Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. CLIN INFECT DIS 2015;61 (9):1453-1461 [PubMed]
  • Boender TS, Hamers RL, Ondoa P, Wellington M, Chimbetete C, Siwale M, Labib Maksimos EEF, Balinda SN, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Stevens W, Rinke de Wit TF, Sigaloff KCE, Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. J INFECT DIS 2016;214 (6):873-883 [PubMed]
  • Lodi S, Günthard HF, Dunn D, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Schneider MP, Egger M, Glass TR, Reiss P, van Sighem A, Boender TS, Phillips AN, Porter K, Hawkins D, Moreno S, Monge S, Paraskevis D, Simeon M, Vourli G, Sabin C, Hernán MA, Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance. AIDS 2018;32 (3):327-335 [PubMed]
All Publications
Other research related activities
  • Membership of advisory board / Consultant, VU University Amsterdam - Health Sciences